SH3BP2 is rarely mutated in exon 9 in giant cell lesions outside cherubism

Clinical Orthopaedics and Related Research

Volumn 459, Issue , 2007, Pages 22-27

  Lietman, Steven A ^a   Prescott, Nichole L ^a   Hicks, David G ^b   Westra, William H ^c   Levine, Michael A ^a,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SH3; TRANSCRIPTION FACTOR NFAT; MESSENGER RNA; NFATC1 PROTEIN, HUMAN; SH3BP2 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; UNCLASSIFIED DRUG;

CONFERENCE PAPER; CONTROLLED STUDY; EXON; FIBROUS DYSPLASIA; GENE MUTATION; GENETIC TRANSCRIPTION; GIANT CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; OSTEOCLASTOMA; PRIORITY JOURNAL; ARTICLE; BONE TUMOR; CASE CONTROL STUDY; GENETICS; METABOLISM; MUTATION; PATHOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BONE NEOPLASMS; CASE-CONTROL STUDIES; CHERUBISM; EXONS; GIANT CELL TUMOR OF BONE; HUMANS; MUTATION; NFATC TRANSCRIPTION FACTORS; RNA, MESSENGER;

EID: 34249931805     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/BLO.0b013e31804b4131     Document Type: Conference Paper

References (39)

1. Battaglia A, Carey JC. Health supervision and anticipatory guidance of individuals with Wolf-Hirschhorn syndrome. Am J Med Genet. 1999;89:111-115.
2. Bell SM, Shaw M, Jou YS, Myers RM, Knowles MA. Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancer. Genomics. 1997;44:163-170.
3. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry. 1979;18:5294-5299.
4. Chomczynski P, Mackey K. One-hour downward capillary blotting of RNA at neutral pH. Anal Biochem. 1994;221:303-305.
5. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA. 1984;81:1991-1995.
6. de Lange J, van den Akker HP. Clinical and radiological features of central giant-cell lesions of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99:464-470.
7. de Lange J, van Maarle MC, van den Akker HP, Redeker EJ. DNA analysis of the SH3BP2 gene in patients with aggressive central giant cell granuloma. Br J Oral Maxillofac Surg. 2006 (ePub ahead of print).
8. Deckert M, Tartare-Deckert S, Hernandez J, Rottapel R, Altman A. Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activation. Immunity. 1998;9:595-605.
9. Font RL, Blanco G, Soparkar CN, Patrinely JR, Ostrowski ML. Giant cell reparative granuloma of the orbit associated with cherubism. Ophthalmology. 2003;110:1846-1849.
10. Foucault I, Le Bras S, Charvet C, Moon C, Altman A, Deckert M. The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor. Blood. 2005;105:1106-1113.
11. Foucault I, Liu YC, Bernard A, Deckert M. The chaperone protein 14-3-3 interacts with 3BP2/SH3BP2 and regulates its adapter function. J Biol Chem. 2003;278:7146-7153.
12. Goldberg DA: Isolation and partial characterization of the Drosophila alcohol dehydrogenase gene. Proc Natl Acad Sci USA. 1980;77:5794-5798.
13. Hirotani H, Tuohy NA, Woo JT, Stern PH, Clipstone NA. The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells. J Biol Chem. 2004; 279:13984-13992.
14. Imai Y, Kanno K, Moriya T, Kayano S, Seino H, Matsubara Y, Yamada A. A missense mutation in the SH3BP2 gene on chromosome 4p16.3 found in a case of nonfamilial cherubism. Cleft Palate Craniofac J. 2003;40:632-638.
15. Jafarov T, Ferimazova N, Reichenberger E. Noonan-like syndrome mutations in PTPN11 in patients diagnosed with cherubism. Clin Genet. 2005;68:190-191.
16. rd, Svirsky JA. Cherubism: diagnosis, treatment, and comparison with central giant cell granulomas and giant cell tumors. Oral Surg Oral Med Oral Pathol. 1992;73:369-374.
17. Lannon DA, Earley MJ. Cherubism and its charlatans. Br J Plast Surg. 2001;54:708-711.
18. Lehrach H, Diamond D, Wozney JM, Boedtker H. RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. Biochemistry. 1977;16: 4743-4751.
19. Lietman SA, Ding C, Levine MA. A highly sensitive polymerase chain reaction method detects activating mutations of the GNAS gene in peripheral blood cells in McCune-Albright syndrome or isolated fibrous dysplasia. J Bone Joint Surg Am. 2005;87: 2489-2494.
20. Lietman SA, Kalinchinko N, Deng X, Kohanski R, Levine MA. Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation. Hum Mutat. 2006;27:717-718.
21. Mahmoudi M, Lin VK. Comparison of two different hybridization systems in northern transfer analysis. Biotechniques. 1989;7:331-334.
22. Marck PA, Kudryk WH. Cherubism. J Otolaryngol. 1992;21:84-87.
23. Meng XM, Yu SF, Yu GY. Clinicopathologic study of 24 cases of cherubism. Int J Oral Maxillofac Surg. 2005;34:350-356.
24. Murphey MD, Nomikos GC, Flemming DJ, Gannon FH, Temple HT, Kransdorf MJ. From the archives of AFIP. Imaging of giant cell tumor and giant cell reparative granuloma of bone: radiologicpathologic correlation. Radiographics. 2001;21:1283-1309.
25. Pawson T, Scott JD. Signaling through scaffold, anchoring, and adaptor proteins. Science. 1997;278:2075-2080.
26. Penarrocha M, Bonet J, Minguez JM, Bagan JV, Vera F, Minguez I. Cherubism: a clinical, radiographic, and histopathologic comparison of 7 cases. J Oral Maxillofac Surg. 2006;64:924-930.
27. Petschler M, Stiller M, Hoffmeister B, Witkowski R, Opitz C, Bill JS, Peters H. Clinical and molecular genetic observations on families with cherubism over three generations. Mund Kiefer Gesichtschir. 2003;7:83-87.
28. Ren R, Mayer BJ, Cicchetti P, Baltimore D. Identification of a ten-amino acid proline-rich SH3 binding site. Science. 1993;259: 1157-1161.
29. Rosen KM, Lamperti ED, Villa-Komaroff L. Optimizing the northern blot procedure. Biotechniques. 1990;8:398-403.
30. Sada K, Miah SM, Maeno K, Kyo S, Qu X, Yamamura H. Regulation of FcepsilonRI-mediated degranulation by an adaptor protein 3BP2 in rat basophilic leukemia RBL-2H3 cells. Blood. 2002;100: 2138-2144.
31. Schwartz HS, Eskew JD, Butler MG. Clonality studies in giant cell tumor of bone. J Orthop Res. 2002;20:387-390.
32. Takayanagi H. Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med. 2005;83:170-179.
33. Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002;3:889-901.
34. Tartaglia M, Kalidas K, Shaw A, Song X, Musat DL, van der Burgt I, Brunner HG, Bertola DR, Crosby A, Ion A, Kucherlapati RS, Jeffery S, Patton MA, Gelb BD. PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity. Am J Hum Genet. 2002;70: 1555-1563.
35. Tiziani V, Reichenberger E, Buzzo CL, Niazi S, Fukai N, Stiller M, Peters H, Salzano FM, Raposo do Amaral CM, Olsen BR. The gene for cherubism maps to chromosome 4p16. Am J Hum Genet. 1999; 65:158-166.
36. Ueki Y, Tiziani V, Santanna C, Fukai N, Maulik C, Garfinkle J, Ninomiya C, doAmaral C, Peters H, Habal M, Rhee-Morris L, Doss JB, Kreiborg S, Olsen BR, Reichenberger E. Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism. Nat Genet. 2001;28:125-126.
37. Vogrincic GS, O'Connell JX, Gilks CB. Giant cell tumor of tendon sheath is a polyclonal cellular proliferation. Hum Pathol. 1997;28: 815-819.
38. West RB, Rubin BP, Miller MA, Subramanian S, Kaygusuz G, Montgomery K, Zhu S, Marinelli RJ, De Luca A, Downs-Kelly E, Goldblum JR, Corless CL, Brown PO, Gilks CB, Nielsen TO, Huntsman D, van de Rijn M. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci USA. 2006; 103:690-695.
39. Yip KM, Leung PC, Kumta SM. Giant cell tumor of bone. Clin Orthop Relat Res. 1996;323:60-64.